Shine Investment Advisory Services’s Globus Medical GMED Stock Holding History

Shine Investment Advisory Services’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$5K	Buy	+111	New	+$5.72K	﹤0.01%	629

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Shine Investment Advisory Services's GMED Position: Q3 2020 in Review

Shine Investment Advisory Services opened a new position in Globus Medical (GMED) in Q3 2020: 111 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #629 among its holdings.

344 funds tracked by Wall St. Rank hold GMED as of Q3 2020.

Shine Investment Advisory Services held 111 shares of Globus Medical worth $5K as of Q3 2020.
Globus Medical was a new Shine Investment Advisory Services position in Q3 2020.
Globus Medical made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #629 holding.
344 funds tracked by Wall St. Rank held Globus Medical as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.